Itonis, Inc. Signs Marketing Agreement for 10,000 Commercial
Spots for Anti-nausea Emesyl homeopathic product
LAGUNA HILLS, CA -- May 18, 2015 -- InvestorsHub NewsWire
-- Itonis, Inc. (OTC
PINKSHEETS: ITNS)
Itonis is pleased to announce that it has signed an agreement to
provide marketing and public relations services for its Emesyl
product, which will include Ten Thousand (10,000) thirty (30)
second commercial spots.
The marketing agreement calls for placing the 10,000 commercial
spots in select regional areas on the most popular cable television
networks available. The networks available to Itonis for airing
selection choice include ESPN, CNN, Fox News, Discovery Channel,
SPIKE, AMC, TBS, Lifetime, A&E, Comedy Central, TV Land,
Nickelodeon, Travel Channel, ESPN2, USA, HLN, BET, MTV, SyFy, CMT,
TLC, TNT, and FX, etc., and have the ability to air more frequently
in any of these select networks.
The agreement additionally provides Itonis, Inc. with National
and International exposure via Internet distribution, and will also
highlight and stream a live broadcast of company representatives on
websites to be announced.
“This marketing effort is our next step to generate branding and
retail sales for Emesyl. Studio production of the commercial
should begin shortly, and we hope to provide a further update as
that task progresses,” said Mark Cheung, CEO, Itonis, Inc. He
further added, “This is a significant start into the television
media that is separate from Hensley Brothers Distributions’ efforts
in its distribution channels.”
About Itonis, Inc.
Located in Laguna Hills, California, and founded in 2005, Itonis
Inc. has focused on the distribution of innovative products to the
medical and pharmaceutical industries. The company also holds a
licensing agreement with MyECheck Inc, which allows the company to
use MyECheck’s patented mobile payment application and share
transaction revenue fees for point of purchase payments across
various industries. Please visit www.itonisholdings.com for additional information.
Safe Harbor:
Statements in this press release may constitute forward-looking
statements and are subject to numerous risks and uncertainties,
including the failure to complete successfully the development of
new or enhanced products, the Company's future capital needs, the
lack of market demand for any new or enhanced products the Company
may develop, any actions by the Company's affiliates that may be
adverse to the Company, the success of competitive products, other
economic factors affecting the Company and its markets, seasonal
changes, and other risks detailed from time to time in the
Company's filings with the U.S. Securities and Exchange Commission.
The actual results may differ materially from those contained in
this press release. The Company disclaims any obligation to update
any statements in this press release.
Contact:
Itonis, Inc.
Office@itonisholdings.com
